COMPASS Pathways CMPS 深 沪
等待开盘 11-13 09:30:00 美东时间
9.12
-0.180
-1.94%
华盛通- 最 高9.335
- 今 开8.94
- 成交量 238.55万股
- 最 低 8.8504
- 昨 收 9.30
- 总市值 12.92亿
- 52周最高 15.87
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 4.88
- 委 比 39.62%
- 总股本 1.42亿
- 历史最高 61.69
- 量 比 0.66
- 振 幅 5.21%
- 历史最低 2.25
- 每 手 1
- 风险率 3.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅132.16%！摩根士丹利上调Riot目标价至41美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Riot Platforms"超配"评级，目标价从35.5美元升至41美元；Canaccord Genuity：维持塞德斯医疗"买入"评级，目标价从60美元升至68美元
11-10 18:30
Compass Pathways Submits FDA New Drug Application For Comp360 Psilocybin For Treatment-Resistant Depression
Robust NDA submission supported by data from two highly statistically significant Phase 3 trials and a Phase 2b study that each met its primary endpoint and involved a total of more than 1,000 participants living with highly chronic TRD Deep commercial capabilities in place to enable successful laun...
11-09 19:33
美股大行评级 | 大摩上调AMD目标价至725美元；安进、多邻国绩后获华尔街大行看多
今日重点评级关注：康托·菲茨杰拉德：维持Supernus"超配"评级，目标价从67美元升至87美元；丰业银行：维持Atlas Energy Solutions"跑赢大市"评级，目标价从17美元升至18美元
11-05 14:06
美股大行评级 | 苹果、雅诗兰黛、莱迪思半导体均获大行上调目标价
今日重点评级关注：Rosenblatt：维持SiTime"买入"评级，目标价从750美元升至900美元；花旗：维持Madrigal Pharmaceuticals"买入"评级，目标价从725美元升至760美元
11-04 18:17
BTIG Reiterates Buy on Compass Pathways, Maintains $25 Price Target
BTIG analyst Thomas Shrader reiterates Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $25 price target.
11-03 23:18
Compass Pathways Q3 EPS $(0.31) Beats $(0.43) Estimate
Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.43) by 27.91 percent. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year.
11-03 19:32
大摩一口气覆盖八家生物科技公司！PTC Therapeutics(PTCT.US)、Belite Bio(BLTE.US)获看好 点名多款潜力重磅药物
摩根士丹利在近日发布的研报中首次覆盖八家生物科技公司，业务涉及罕见病、眼科、肺部疾病以及神经精神疾病领域。
10-20 09:40
Compass Pathways To Participate In Psych Congress 2026 With New Educational Campaign Regarding Treatment-Resistant Depression
Congress taking place in New Orleans, LA, from September 14-19. The Company will debut Change the Tune in TRD, a new educational campaign for U.S. HCPs focused on TRD, and present new HEOR data examining the burden of TRD alongside encore presentations from its COMP360 psilocybin clinical developmen...
09-08 18:36
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
Compass Pathways Plc (($CMPS)) has held its Q2 earnings call. Read on for the m...
08-21 08:21
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
